Utah lets an AI system renew chronic-condition prescriptions in a state pilot
On January 6, 2026, Utah's Office of Artificial Intelligence Policy and the startup Doctronic announced a 12-month pilot, set up through the state's regulatory sandbox, in which Doctronic's AI renews routine prescriptions for chronic conditions such as diabetes and hypertension. Reports put the list at about 192 drugs. Controlled substances, ADHD medications and injectables are excluded, and the first prescription must still come from a human clinician. The state agreed not to enforce its unprofessional-conduct rules against Doctronic as long as the company follows a contract with safety and privacy terms. Physicians review the AI's decisions at first, and uncertain cases are sent to clinicians. Doctronic told regulators its system matched physician treatment plans in 99.2% of 500 urgent care cases it reviewed.
Why it's notable: It is the first state-approved program in the US to let an AI system renew prescriptions on its own, which makes it a test case for how states may license autonomous clinical AI.